News and Press Releases

Enable Injections Announces Regulatory Approval in Saudi Arabia for the EMPAVELI® Injector based on enFuse® Technology

December 18, 2025 – Globe Newswire

Incyte and Enable Injections Announce Strategic Partnership for enFuse® On-Body Delivery System

October 27, 2025 – Incyte

Enable Injections Announces enFuse® System Regulatory Approval in Brazil and MRHA Medical Device Registration in the UK

August 12, 2025 – Globe Newswire

ASCO: new Sarclisa data support subcutaneous administration with on-body injector

June 3, 2025 – Sanofi.com

Enable Injections Presents Survey Results Highlighting Missed Opportunities in Subcutaneous Oncology Drug Development at AACR 2025

April 25, 2025 – Globe Newswire

Enable Injections Announces Regulatory CE Mark Approval in Europe for enFuse Technology

March 25, 2025 – Globe Newswire

New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma

January 9, 2025 – Sanofi.com